Regulatory guidance and project coordination

Product Compliance And Certification For Protein Powder In The USA

Scope and evidence must be confirmed before any paid tests or filings.

Determine the route before designing the tub

A US protein powder has no universal “FDA certification.” First decide whether the actual formula, presentation, directions, and advertising make it a conventional food, a dietary supplement, or a product with drug-type claims. A powder format and the word “protein” alone settle none of those questions. [FDA][FDA]

A dietary supplement must supplement the diet, be labeled as such, and not be represented as conventional food or as the sole item of a meal or diet. “Use as a meal replacement” is therefore a classification red flag, not a decorative marketing phrase. Freeze product positioning before commissioning the Nutrition Facts or Supplement Facts panel. [FDA]

Three questions that change the legal route

  1. Is the powder sold as a dietary add-on, an ordinary food ingredient, or a complete meal? Review website, package and serving directions together.
  2. Is the protein whey, casein, soy, pea, collagen or a blend—and are vitamins, botanicals or novel additives present?
  3. Will it be made in the US or imported, marketed to competitive athletes, labeled organic, or sold with muscle/recovery claims?

Regulatory layers for six protein-powder scenarios

Use the matrix as a screening tool, not a product-specific legal determination. One SKU can engage FDA ingredient, labeling and manufacturing rules, import controls, FTC advertising oversight and optional certification programs simultaneously.

Product presentation / triggerLikely regulatory stackWhat to verify before launch
Whey/casein isolate sold explicitly as a dietary supplementSupplement route may fit if statutory conditions are met; Part 111, Supplement Facts, milk allergenConfirm no meal-replacement presentation; verify each ingredient and protein content
Pea/soy powder sold as a smoothie or recipe foodConventional food may be the route; Part 117 as applicable, Nutrition Facts, soy where relevantCheck food-use status, allergen sources and serving/claim basis
“Complete meal” protein blend with fats and carbohydratesMeal-substitute presentation undermines supplement route; reassess as conventional foodReview total positioning, nutrient profile and target consumers
Protein plus botanicals, stimulants or new specialty compoundsAdditional safety/status analysis; NDI question if supplement, food-additive/GRAS if foodObtain identity, use history, quantity and safety evidence before launch
Imported finished tubs or foreign-manufactured bulk powderFDA facility/import requirements and FSVP allocation may applyName importer and verify supplier, registration and prior notice
Athlete-targeted or “organic” branded SKUCore FDA/FTC duties plus optional private sport certification or conditional USDA organic certificationFor sport seals, verify the exact certified SKU/flavor and program lot scope; separately verify USDA-certified operation, organic-label category and ingredient traceability

Decision aid—not an FDA determination. Requirements vary with the complete SKU and use.

Evidence package by decision gate

For each proposed flavor and protein source, compile the following traceable file. A supplier certificate of analysis alone does not establish a finished product’s regulatory status or all mandatory manufacturing verification. [FDA]

For conventional foods, assess ingredients and intended uses under applicable food-additive authorizations, GRAS conclusions or other exclusions. For supplements, assess whether each component qualifies and whether a new dietary ingredient (NDI) notification is triggered; where the statutory conditions apply, filing must precede marketing by at least 75 days. An ordinary whey or pea formula does not automatically require an NDI filing merely because it is new to your brand. [FDA][NDI]

Evidence itemMinimum decision input
Classification memorandumFull pack artwork, website screenshots, use directions, audience, and food-versus-supplement rationale
Formula and ingredient statusBill of materials by weight, source species, botanical/novel ingredients, safety and US permitted-use analysis
Protein and contaminant substantiationProtein analytical method and quality basis where claims require it; risk-based microbial, heavy-metal and allergen evidence
Factory and lot recordsApplicable CGMP system, ingredient specifications, batch records, supplier qualification and deviation handling
Label and claim dossierFacts-panel calculations, major-allergen declarations, claims substantiation, final digital and print proofs
Market entry and optional sealsFacility/FSVP/prior-notice assignments if imported; separate USDA organic or third-party certification proof if claimed

Protein claims and allergen traps on the US label

Match the facts panel to classification: conventional foods generally use Nutrition Facts under 21 CFR 101.9; supplements use Supplement Facts under 21 CFR 101.36. Evaluate serving size, protein grams, other nutrients, ingredient statement, net quantity, business details and any required supplement-specific contact information. A declared “high protein” claim on conventional food also raises protein-quality-adjusted % Daily Value issues; protein grams by themselves do not prove the claim is permissible. [FDA][FDA]

For conventional-food labeling, FDA distinguishes the declared grams of protein from protein % Daily Value: the latter uses a digestibility-corrected amino-acid score under 21 CFR 101.9(c)(7). Before using “high protein,” verify the relevant claim threshold, reference amount and serving size against both the analytical protein amount and the quality-adjusted %DV; “25 g per scoop” or a supplier certificate alone does not establish eligibility. [FDA]

Whey and casein implicate milk; soy protein implicates soy. Investigate the nine major US allergens, including sesame, throughout ingredients and composite flavors. Declare the legally required food source on the label and document cross-contact controls; a voluntary “may contain” statement is not a substitute for preventive controls. [FDA]

For sales into California, assess a separate Proposition 65 layer: determine whether expected consumer exposure to listed chemicals, such as lead where relevant, triggers a legally required warning. Detection of a trace amount alone is not a definitive warning decision; evaluate exposure, applicable safe-harbor levels or exemptions, and the sales channel. A compliant federal FDA label does not resolve this state-level question. [OEHHA]

Production controls and imported stock

A conventional-food manufacturer generally evaluates 21 CFR Part 117 CGMP and applicable preventive controls. A dietary-supplement operation follows Part 111; the Part 117 preventive-control exclusions for qualifying finished supplements are conditional, not a blanket exemption for dietary-ingredient production. Facilities that must register with FDA must do so and renew in even-numbered years; the current renewal window is 1 October–31 December 2026. [FDA][FDA][FDA]

The 21 CFR 117.5(e) exclusion concerns Part 117 Subparts C and G for qualifying dietary-supplement activities where Part 111 and the statutory serious-adverse-event reporting requirements are met. It is not an exemption from every provision of Part 117, nor does it automatically cover manufacture of a dietary ingredient sold for food use. [FDA]

For imports, identify the foreign facility, any required US agent for facility registration, US FSVP importer and the shipment’s prior-notice pathway. FSVP has dietary-supplement-specific modified provisions; do not assume a generic food-import checklist fits every protein powder. [FSVP][FDA]

Do not confuse the FSVP importer with the customs importer of record or the facility-registration US agent. Ordinarily the FSVP importer is the US owner or consignee at entry, or—if neither exists—a US agent or representative of the foreign owner confirmed by written consent. FDA distinguishes imported dietary-supplement components whose Part 111 specifications are established and verified from imported finished supplements: some component importers are relieved of most standard FSVP duties, while finished-supplement importers generally retain most, other than hazard analysis, with verification focused on supplement CGMP. Determine the precise exemption or modification for the actual shipment. [FDA]

What “certified” can—and cannot—mean

FDA generally does not preapprove dietary supplements or certify protein powders. USDA organic labeling depends on a separate organic-rule/certification pathway, with specified exemptions; independent NSF or sports-banned-substance screening is voluntary and does not replace FDA compliance. “FDA registered facility,” “laboratory tested,” and “FDA approved protein powder” are materially different claims. [FDA][USDA]

Health/performance ads need substantiation under FTC principles. For qualifying supplement structure/function statements in labeling, there is a prescribed disclaimer and an FDA notification within 30 days after first marketing; disease-treatment claims can raise drug classification. Supplement labels also need a domestic address or telephone number for adverse-event reports. Changing the label, flavor or sales claims may reopen earlier gates. [FTC][FDA][FDA]

A five-gate release sequence

  1. Lock intended use and classify the finished presentation—not just the powder chemistry.
  2. Resolve every ingredient’s legal use and any NDI or additive decision.
  3. Approve factory controls and risk-based specifications; verify actual production evidence.
  4. Approve the correct facts panel, allergens and all package/digital claims.
  5. Allocate import responsibilities, verify optional seals and release only the documented SKU; reassess material changes.

For athlete-wide categories beyond powder, see US sports-nutrition route map. A Canadian launch is a separate classification exercise: protein powder in Canada.

Protein powder: decision FAQs

Can an unflavored whey protein powder always use Supplement Facts?
No. Whey is not an automatic classification. The intended dietary-supplement use, label identity and absence of conventional-food or meal-substitute presentation must be assessed together.
If a scoop says “25 g protein,” do we have enough for a “high protein” claim?
Not necessarily. Review the applicable nutrient-content claim rule, protein quality and relevant protein %DV calculation, as well as testing and serving size.
Does a pea protein blend need an NDI notification?
Not solely because it uses pea protein. Determine each dietary ingredient’s historical and regulatory status and the conditions of any statutory exception; specialized added ingredients may change the answer.
May an overseas co-packer use its FDA facility registration as proof the tubs are approved?
No. Facility registration is not product approval. Confirm the importer/FSVP role, applicable factory CGMP, label compliance and prior notice separately.
Is NSF Certified for Sport or USDA Organic legally required for every protein powder?
No general federal requirement makes either universal. An organic claim must meet USDA organic rules; private sports certification is voluntary but may be required by a buyer or sports organization.

Primary official references

The URLs below are US regulator or certification-program source materials; guidance describes agency thinking and is not itself a substitute for binding statutory/regulatory text.

Responsible for publication: Khachatrian Razmik

Last updated: 2026-10-16

Related guidance